6308-22-1 Usage
Uses
Used in Pharmaceutical Development:
AKOS B018304 is used as a potential pharmaceutical candidate for drug development due to its unique structural features and potential biological activities.
Used in Organic Synthesis:
AKOS B018304 is used as a building block in the synthesis of various organic compounds, contributing to the creation of new chemical entities with potential applications in different fields.
Used in Academic Research:
AKOS B018304 is utilized in academic research to explore its properties, reactivity, and potential applications in the development of new chemical reactions and methodologies.
Used in Chemical Reactions and Methodologies Development:
AKOS B018304 is employed in the development of new chemical reactions and methodologies, enhancing the understanding of its reactivity and potential use in creating novel chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 6308-22-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,0 and 8 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 6308-22:
(6*6)+(5*3)+(4*0)+(3*8)+(2*2)+(1*2)=81
81 % 10 = 1
So 6308-22-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H6N2O3S2/c13-9-8(17-10(16)11-9)5-6-3-1-2-4-7(6)12(14)15/h1-5H,(H,11,13,16)/b8-5+
6308-22-1Relevant academic research and scientific papers
Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors
Li, Si-Ning,Xu, Yun-Yun,Gao, Jia-Yu,Yin, Hong-Ran,Zhang, Shi-Lei,Li, Huan-Qiu
, p. 3221 - 3227 (2015/08/03)
Abstract A type of novel rhodanine-based 4-anilinoquinazoline, which designed the combination between quinazoline as the backbone and various substituted biological rhodanine groups as the side chain, have been synthesized, and their antiproliferative act
